Literature DB >> 6198062

Steroid hormone binding macromolecules in meningiomas. Failure to meet criteria of specific receptors.

M R Schwartz, R L Randolph, D A Cech, J E Rose, W B Panko.   

Abstract

Cytoplasmic estrogen and progesterone binding proteins were assayed in 26 meningiomas using an assay developed for the measurement of estrogen and progesterone receptors in human target tissue. The steroid specificity of the binding proteins was studied in both individual and pooled meningioma tissue by competitive binding assays. Eight meningiomas contained significant amounts of estrogen-binding protein and 18 contained significant amounts of progesterone-binding protein. There was no correlation between the amount of hormone-binding protein and patient age, sex, menstrual status or presentation, or tumor occurrence, location, or pathologic features. The competition studies demonstrated a lack of steroid specificity for these hormone-binding proteins. Therefore, the authors conclude that, contrary to recent reports, the hormone-binding proteins found in meningiomas are unlikely to be specific steroid receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198062     DOI: 10.1002/1097-0142(19840215)53:4<922::aid-cncr2820530418>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Expression of estrogen receptors alpha and beta in human meningiomas.

Authors:  R S Carroll; J Zhang; P M Black
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

2.  Hormonal modulation of brain tumour growth: a cell culture study.

Authors:  N Gibelli; C Zibera; G Butti; R Assietti; G Sica; M Scerrati; F Iacopino; R Roselli; P Paoletti; G Robustelli della Cuna
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 3.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

4.  Newly diagnosed primary intracranial neoplasms in pregnant women: a population-based assessment.

Authors:  J F Haas; W Jänisch; W Staneczek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

5.  Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.

Authors:  J Jääskeläinen; E Laasonen; J Kärkkäinen; M Haltia; H Troupp
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

6.  Progestin receptors in meningiomas. Comparison of cytosolic assays with immunocytochemical identification in cryostat and paraffin sections.

Authors:  G Blaauw; J Koudstaal; M A Blankenstein; M Debets-Te Baerts; A H Gijzen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

Authors:  J W Ironside; R D Battersby; V J Dangerfield; M A Parsons; W R Timperley; J C Underwood
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

8.  Sex steroid receptors in human meningiomas.

Authors:  G Blaauw; M A Blankenstein; S W Lamberts
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.